Endava Announces Second Quarter Fiscal Year 2022 Results
Endava plc (NYSE: DAVA) reported a strong Q2 FY2022 with revenue growth of 49.8% year-on-year, reaching £157.7 million. The revenue growth rate at constant currency was 53.4%, compared to 21.4% in the previous year. Diluted EPS rose to £0.27 from £0.14, while adjusted diluted EPS improved to £0.46 from £0.29. Net cash from operating activities also increased to £35.0 million. Looking ahead, Endava forecasts Q3 revenues between £161.0 million and £163.0 million, with adjusted diluted EPS guidance of £0.42 to £0.44.
- Revenue increased to £157.7 million, 49.8% YoY growth.
- Adjusted diluted EPS rose to £0.46, up from £0.29 YoY.
- Net cash from operating activities was £35.0 million, an increase from £20.4 million YoY.
- Revenue growth at constant currency reached 53.4%.
- None.
Q2 FY2022
IFRS diluted EPS
Adjusted diluted EPS
“Endava continued our strong growth in all regions and verticals – helping clients digitally accelerate and innovate,” said
SECOND QUARTER FISCAL YEAR 2022 FINANCIAL HIGHLIGHTS:
-
Revenue for Q2 FY2022 was
£157.7 million , an increase of49.8% compared to£105.2 million in the same period in the prior year.
-
Revenue growth rate at constant currency (a non-IFRS measure) was
53.4% for Q2 FY2022, compared to21.4% in the same period in the prior year.
-
Profit before tax for Q2 FY2022 was
£19.1 million , compared to£10.6 million in the same period in the prior year.
-
Adjusted profit before tax (a non-IFRS measure) for Q2 FY2022 was
£33.0 million , compared to£20.6 million in the same period in the prior year, or20.9% of revenue, compared to19.6% of revenue in the same period in the prior year.
-
Profit for the period was
£15.4 million in Q2 FY2022, resulting in a diluted EPS of£0.27 , compared to profit of£7.8 million and diluted EPS of£0.14 in the same period in the prior year.
-
Adjusted profit for the period (a non-IFRS measure) was
£26.5 million in Q2 FY2022, resulting in adjusted diluted EPS (a non-IFRS measure) of£0.46 , compared to adjusted profit for the period of£16.4 million and adjusted diluted EPS of£0.29 in the same period in the prior year.
CASH FLOW:
-
Net cash from operating activities was
£35.0 million in Q2 FY2022, compared to£20.4 million in the same period in the prior year.
-
Adjusted free cash flow (a non-IFRS measure) was
£31.2 million in Q2 FY2022, compared to£18.7 million in the same period in the prior year.
-
At
December 31, 2021 ,Endava had cash and cash equivalents of£114.2 million , compared to£69.9 million atJune 30, 2021 .
OTHER METRICS FOR THE QUARTER ENDED
-
Headcount reached 10,391 at
December 31, 2021 , with 9,167 average operational employees in Q2 FY2022, compared to a headcount of 7,464 atDecember 31, 2020 and 6,629 average operational employees in the same quarter of the prior year.
-
Number of clients with over
£1 million in revenue on a rolling twelve months basis was 107 atDecember 31, 2021 , compared to 75 atDecember 31, 2020 .
-
Top 10 clients accounted for
34% of revenue in Q2 FY2022, compared to37% in the same period in the prior year.
-
By geographic region,
35% of revenue was generated inNorth America ,21% was generated inEurope ,41% was generated in theUnited Kingdom and3% was generated in the rest of the world in Q2 FY2022. This compares to29% inNorth America ,27% inEurope ,42% in theUnited Kingdom and2% in the rest of the world in the same period in the prior year.
-
By industry vertical,
51% of revenue was generated from Payments and Financial Services,25% from TMT and24% from Other in Q2 FY2022. This compares to49% from Payments and Financial Services,28% from TMT and23% from Other in the same period in the prior year.
OUTLOOK:
Third Quarter Fiscal Year 2022:
Full Fiscal Year 2022:
This above guidance for Q3 Fiscal Year 2022 and the Full Fiscal Year 2022 assumes the exchange rates at the end of January (when the exchange rate was
The guidance provided above is forward-looking in nature. Actual results may differ materially. See the cautionary note regarding “Forward-Looking Statements” below.
CONFERENCE CALL DETAILS:
The Company will host a conference call at
Investors may listen to the call on Endava’s Investor Relations website at http://investors.Endava.com. The webcast will be recorded and available for replay until
ABOUT
NON-IFRS FINANCIAL INFORMATION:
To supplement Endava’s Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets and Consolidated Statements of Cash Flow presented in accordance with IFRS, the Company uses non-IFRS measures of certain components of financial performance. These measures include: revenue growth rate at constant currency, revenue growth at constant currency adjusted for the sale of Endava Technology SRL, also referred to as “the Worldpay Captive” to Worldpay on
Revenue growth rate at constant currency is calculated by translating revenue from entities reporting in foreign currencies into British Pounds using the comparable foreign currency exchange rates from the prior period. For example, the average rates in effect for the fiscal quarter ended
Revenue growth at constant currency adjusted for the sale of the Worldpay Captive is revenue growth at constant currency adjusted to exclude the impact of the sale of the Worldpay Captive.
Adjusted profit before tax ("Adjusted PBT") is defined as the Company’s profit before tax adjusted to exclude the impact of share-based compensation expense, amortisation of acquired intangible assets and, realised and unrealised foreign currency exchange (gains)/losses, all of which are non-cash items. Adjusted PBT margin is Adjusted PBT as a percentage of total revenue.
Adjusted profit for the period is defined as Adjusted PBT together with the tax impact of these adjustments.
Adjusted diluted EPS is defined as Adjusted profit for the period, divided by weighted average number of shares outstanding - diluted.
Adjusted free cash flow is the Company’s net cash from operating activities, plus grants received, less net purchases of non-current assets (tangible and intangible).
Management believes these measures help illustrate underlying trends in the Company's business and uses the measures to establish budgets and operational goals, communicated internally and externally, for managing the Company's business and evaluating its performance. Management also believes the presentation of its non-IFRS financial measures enhances an investor’s overall understanding of the Company’s historical financial performance. The presentation of the Company’s non-IFRS financial measures is not meant to be considered in isolation or as a substitute for the Company’s financial results prepared in accordance with IFRS, and its non-IFRS measures may be different from non-IFRS measures used by other companies. Investors should review the reconciliation of the Company’s non-IFRS financial measures to the comparable IFRS financial measures included below, and not rely on any single financial measure to evaluate the Company’s business.
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by the use of terms and phrases such as “believe,” “expect,” "outlook," “may,” “will”, and other similar terms and phrases. Such forward-looking statements include, but are not limited to, the statements regarding Endava’s projected financial performance for the third fiscal quarter of fiscal year 2022 and the full fiscal year 2022. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: Endava’s business, results of operations and financial condition may be negatively impacted by the COVID-19 pandemic and the precautions taken in response to the pandemic or if general economic conditions in
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|
Six Months Ended |
Three Months Ended |
||||||
|
2021 |
2020(1) |
2021 |
2020(1) |
||||
|
£’000 |
£’000 |
£’000 |
£’000 |
||||
REVENUE |
305,133 |
|
200,365 |
|
157,668 |
|
105,240 |
|
Cost of sales |
|
|
|
|
||||
Direct cost of sales |
(189,292 |
) |
(120,479 |
) |
(99,806 |
) |
(63,003 |
) |
Allocated cost of sales |
(11,090 |
) |
(9,912 |
) |
(5,800 |
) |
(5,180 |
) |
Total cost of sales |
(200,382 |
) |
(130,391 |
) |
(105,606 |
) |
(68,183 |
) |
GROSS PROFIT |
104,751 |
|
69,974 |
|
52,062 |
|
37,057 |
|
Selling, general and administrative expenses |
(59,624 |
) |
(41,615 |
) |
(31,981 |
) |
(21,188 |
) |
Net impairment losses on financial assets |
(1,812 |
) |
(2,646 |
) |
(651 |
) |
(1,806 |
) |
OPERATING PROFIT |
43,315 |
|
25,713 |
|
19,430 |
|
14,063 |
|
Net Finance income / (expense) |
683 |
|
(6,380 |
) |
(354 |
) |
(3,455 |
) |
PROFIT BEFORE TAX |
43,998 |
|
19,333 |
|
19,076 |
|
10,608 |
|
Tax on profit on ordinary activities |
(8,047 |
) |
(4,826 |
) |
(3,670 |
) |
(2,809 |
) |
PROFIT FOR THE PERIOD |
35,951 |
|
14,507 |
|
15,406 |
|
7,799 |
|
OTHER COMPREHENSIVE INCOME |
|
|
|
|
||||
Items that may be reclassified subsequently to profit or loss: |
|
|
|
|
||||
Exchange differences on translating foreign operations |
(1,528 |
) |
(3,491 |
) |
(3,577 |
) |
(2,644 |
) |
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD ATTRIBUTABLE TO OWNERS OF THE PARENT |
34,423 |
|
11,016 |
|
11,829 |
|
5,155 |
|
|
|
|
|
|
||||
EARNINGS PER SHARE (EPS): |
|
|
|
|
||||
Weighted average number of shares outstanding - Basic |
55,911,086 |
|
54,831,134 |
|
56,173,171 |
|
55,168,042 |
|
Weighted average number of shares outstanding - Diluted |
57,880,029 |
|
56,850,290 |
|
58,019,316 |
|
57,107,940 |
|
Basic EPS (£) |
0.64 |
|
0.26 |
|
0.27 |
|
0.14 |
|
Diluted EPS (£) |
0.62 |
|
0.26 |
|
0.27 |
|
0.14 |
|
(1) The presentation of the income statement has been changed to separately disclose the net impairment losses on financial assets on the face of the Consolidated Statement of Comprehensive Income (refer to Note 3C of our Annual Report on Form 20-F for the fiscal year ended
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
|
|
|||
|
£’000 |
£’000 |
£’000 |
|||
ASSETS - NON-CURRENT |
|
|
|
|||
|
124,591 |
|
124,417 |
|
102,739 |
|
Intangible assets |
64,362 |
|
69,550 |
|
34,961 |
|
Property, plant and equipment |
17,273 |
|
13,324 |
|
11,985 |
|
Lease right-of-use assets |
51,688 |
|
57,193 |
|
46,836 |
|
Deferred tax assets |
21,406 |
|
18,674 |
|
13,552 |
|
Financial assets |
189 |
|
363 |
|
639 |
|
TOTAL |
279,509 |
|
283,521 |
|
210,712 |
|
ASSETS - CURRENT |
|
|
|
|||
Trade and other receivables |
143,840 |
|
118,303 |
|
91,527 |
|
Corporation tax receivable |
1,193 |
|
938 |
|
2,611 |
|
Financial assets |
444 |
|
563 |
|
577 |
|
Cash and cash equivalents |
114,176 |
|
69,884 |
|
84,221 |
|
TOTAL |
259,653 |
|
189,688 |
|
178,936 |
|
TOTAL ASSETS |
539,162 |
|
473,209 |
|
389,648 |
|
LIABILITIES - CURRENT |
|
|
|
|||
Lease liabilities |
11,960 |
|
13,543 |
|
12,150 |
|
Trade and other payables |
94,060 |
|
78,634 |
|
63,121 |
|
Corporation tax payable |
384 |
|
4,294 |
|
1,865 |
|
Contingent consideration |
5,904 |
|
5,718 |
|
1,091 |
|
Deferred consideration |
6,789 |
|
624 |
|
2,786 |
|
TOTAL |
119,097 |
|
102,813 |
|
81,013 |
|
LIABILITIES - NON CURRENT |
|
|
|
|||
Lease liabilities |
44,648 |
|
50,142 |
|
39,141 |
|
Deferred tax liabilities |
8,787 |
|
10,010 |
|
5,497 |
|
Deferred consideration |
2,831 |
|
9,370 |
|
5,017 |
|
Other liabilities |
191 |
|
205 |
|
138 |
|
TOTAL |
56,457 |
|
69,727 |
|
49,793 |
|
EQUITY |
|
|
|
|||
Share capital |
1,130 |
|
1,114 |
|
1,110 |
|
Share premium |
4,541 |
|
247 |
|
230 |
|
Merger relief reserve |
30,003 |
|
30,003 |
|
25,527 |
|
Retained earnings |
343,216 |
|
283,059 |
|
239,469 |
|
Other reserves |
(15,127 |
) |
(13,599 |
) |
(7,308 |
) |
Investment in own shares |
(155 |
) |
(155 |
) |
(186 |
) |
TOTAL |
363,608 |
|
300,669 |
|
258,842 |
|
TOTAL LIABILITIES AND EQUITY |
539,162 |
|
473,209 |
|
389,648 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|
Six Months Ended |
Three Months Ended |
||||||
|
2021 |
2020 |
2021 |
2020 |
||||
|
£’000 |
£’000 |
£’000 |
£’000 |
||||
OPERATING ACTIVITIES |
|
|
|
|
||||
Profit for the period |
35,951 |
|
14,507 |
|
15,406 |
|
7,799 |
|
Income tax charge |
8,047 |
|
4,826 |
|
3,670 |
|
2,809 |
|
Non-cash adjustments |
32,970 |
|
27,486 |
|
18,228 |
|
15,069 |
|
Tax paid |
(5,701 |
) |
(648 |
) |
(3,468 |
) |
(800 |
) |
|
— |
|
1,311 |
|
— |
|
1,311 |
|
Net changes in working capital |
(16,396 |
) |
(5,599 |
) |
1,126 |
|
(5,775 |
) |
Net cash from operating activities |
54,871 |
|
41,883 |
|
34,962 |
|
20,413 |
|
|
|
|
|
|
||||
INVESTING ACTIVITIES |
|
|
|
|
||||
Purchase of non-current assets (tangibles and intangibles) |
(7,398 |
) |
(2,344 |
) |
(3,836 |
) |
(1,703 |
) |
Proceeds from disposal of non-current assets |
171 |
|
108 |
|
59 |
|
43 |
|
Acquisition of subsidiaries, consideration in cash |
(611 |
) |
(52,132 |
) |
— |
|
(1,342 |
) |
Cash and cash equivalents acquired with subsidiaries |
— |
|
1,603 |
|
— |
|
— |
|
Interest received |
20 |
|
53 |
|
11 |
|
26 |
|
Net cash used in investing activities |
(7,818 |
) |
(52,712 |
) |
(3,766 |
) |
(2,976 |
) |
|
|
|
|
|
||||
FINANCING ACTIVITIES |
|
|
|
|
||||
Proceeds from sublease |
277 |
|
289 |
|
142 |
|
132 |
|
Repayment of lease liabilities |
(7,123 |
) |
(5,746 |
) |
(3,322 |
) |
(2,792 |
) |
Interest paid |
(475 |
) |
(444 |
) |
(226 |
) |
(233 |
) |
Grant received / (paid) |
43 |
|
220 |
|
42 |
|
(89 |
) |
Issue of shares |
4,299 |
|
9 |
|
4,299 |
|
1 |
|
Net cash from financing activities |
(2,979 |
) |
(5,672 |
) |
935 |
|
(2,981 |
) |
Net change in cash and cash equivalents |
44,074 |
|
(16,501 |
) |
32,131 |
|
14,456 |
|
|
|
|
|
|
||||
Cash and cash equivalents at the beginning of the period |
69,884 |
|
101,327 |
|
82,034 |
|
70,039 |
|
Exchange differences on cash and cash equivalents |
218 |
|
(605 |
) |
11 |
|
(274 |
) |
Cash and cash equivalents at the end of the period |
114,176 |
|
84,221 |
|
114,176 |
|
84,221 |
|
RECONCILIATION OF IFRS FINANCIAL MEASURES TO NON-IFRS FINANCIAL MEASURES
RECONCILIATION OF REVENUE GROWTH RATE AS REPORTED UNDER IFRS TO REVENUE GROWTH RATE AT CONSTANT CURRENCY:
|
Six Months ended |
Three Months ended |
||||||
|
2021 |
2020 |
2021 |
2020 |
||||
REVENUE GROWTH RATE AS REPORTED UNDER IFRS |
52.3 |
% |
19.1 |
% |
49.8 |
% |
22.5 |
% |
Foreign exchange rates impact |
4.6 |
% |
0.1 |
% |
3.6 |
% |
(1.1 |
%) |
REVENUE GROWTH RATE AT CONSTANT CURRENCY INCLUDING WORLDPAY CAPTIVE |
56.9 |
% |
19.2 |
% |
53.4 |
% |
21.4 |
% |
Impact of Worldpay Captive |
— |
|
1.6 |
% |
— |
|
— |
|
PRO-FORMA REVENUE GROWTH RATE AT CONSTANT CURRENCY ADJUSTED FOR THE SALE OF THE WORLDPAY CAPTIVE |
56.9 |
% |
20.8 |
% |
53.4 |
% |
21.4 |
% |
RECONCILIATION OF ADJUSTED PROFIT BEFORE TAX AND ADJUSTED PROFIT FOR THE PERIOD:
|
Six Months Ended |
Three Months Ended |
||||||
|
2021 |
2020 |
2021 |
2020 |
||||
|
£’000 |
£’000 |
£’000 |
£’000 |
||||
|
|
|
|
|
||||
PROFIT BEFORE TAX |
43,998 |
|
19,333 |
|
19,076 |
|
10,608 |
|
Adjustments: |
|
|
|
|
||||
Share-based compensation expense |
20,916 |
|
11,896 |
|
11,758 |
|
5,965 |
|
Amortisation of acquired intangible assets |
4,941 |
|
2,280 |
|
2,480 |
|
1,114 |
|
Foreign currency exchange (gains) / losses, net |
(2,060 |
) |
5,304 |
|
(303 |
) |
2,892 |
|
Total adjustments |
23,797 |
|
19,480 |
|
13,935 |
|
9,971 |
|
ADJUSTED PROFIT BEFORE TAX |
67,795 |
|
38,813 |
|
33,011 |
|
20,579 |
|
|
|
|
|
|
||||
PROFIT FOR THE PERIOD |
35,951 |
|
14,507 |
|
15,406 |
|
7,799 |
|
Adjustments: |
|
|
|
|
||||
Adjustments to profit before tax |
23,797 |
|
19,480 |
|
13,935 |
|
9,971 |
|
Tax impact of adjustments |
(4,977 |
) |
(2,966 |
) |
(2,870 |
) |
(1,416 |
) |
ADJUSTED PROFIT FOR THE PERIOD |
54,771 |
|
31,021 |
|
26,471 |
|
16,354 |
|
|
|
|
|
|
||||
Diluted EPS (£) |
0.62 |
|
0.26 |
|
0.27 |
|
0.14 |
|
Adjusted diluted EPS (£) |
0.95 |
|
0.55 |
|
0.46 |
|
0.29 |
|
RECONCILIATION OF NET CASH FROM OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
|
Six Months Ended |
Three Months Ended |
||||||
|
2021 |
2020 |
2021 |
2020 |
||||
|
£’000 |
£’000 |
£’000 |
£’000 |
||||
|
|
|
|
|
||||
Net cash from operating activities |
54,871 |
|
41,883 |
|
34,962 |
|
20,413 |
|
Adjustments: |
|
|
|
|
||||
Grant received |
43 |
|
220 |
|
42 |
|
(89 |
) |
Purchases of non-current assets (tangibles and intangibles) |
(7,227 |
) |
(2,236 |
) |
(3,777 |
) |
(1,660 |
) |
Adjusted Free cash flow |
47,687 |
|
39,867 |
|
31,227 |
|
18,664 |
|
SUPPLEMENTARY INFORMATION
SHARE-BASED COMPENSATION EXPENSE
|
Six Months Ended |
Three Months Ended |
||
|
2021 |
2020 |
2021 |
2020 |
|
£’000 |
£’000 |
£’000 |
£’000 |
|
|
|
|
|
Direct cost of sales |
12,675 |
7,064 |
7,329 |
3,566 |
Selling, general and administrative expenses |
8,241 |
4,832 |
4,429 |
2,399 |
Total |
20,916 |
11,896 |
11,758 |
5,965 |
DEPRECIATION AND AMORTISATION
|
Six Months Ended |
Three Months Ended |
||
|
2021 |
2020 |
2021 |
2020 |
|
£’000 |
£’000 |
£’000 |
£’000 |
|
|
|
|
|
Direct cost of sales |
8,024 |
7,863 |
4,108 |
4,293 |
Selling, general and administrative expenses |
6,162 |
3,568 |
3,105 |
1,795 |
Total |
14,186 |
11,431 |
7,213 |
6,088 |
EMPLOYEES, TOP 10 CUSTOMERS AND REVENUE SPLIT
|
Six Months Ended |
Three Months Ended |
||||||
|
2021 |
2020 |
2021 |
2020 |
||||
|
|
|
|
|
||||
Closing number of total employees (including directors) |
10,391 |
|
7,464 |
|
10,391 |
|
7,464 |
|
Average operational employees |
8,825 |
|
6,417 |
|
9,167 |
|
6,629 |
|
|
|
|
|
|
||||
Top 10 customers % |
35 |
% |
38 |
% |
34 |
% |
37 |
% |
Number of clients with > (rolling 12 months) |
107 |
|
75 |
|
107 |
|
75 |
|
|
|
|
|
|
||||
Geographic split of revenue % |
|
|
|
|
||||
|
36 |
% |
29 |
% |
35 |
% |
29 |
% |
|
20 |
% |
26 |
% |
21 |
% |
27 |
% |
|
41 |
% |
43 |
% |
41 |
% |
42 |
% |
Rest of World (RoW) |
3 |
% |
2 |
% |
3 |
% |
2 |
% |
Industry vertical split of revenue % |
|
|
|
|
||||
Payments and Financial Services |
50 |
% |
50 |
% |
51 |
% |
49 |
% |
TMT |
25 |
% |
28 |
% |
25 |
% |
28 |
% |
Other |
25 |
% |
22 |
% |
24 |
% |
23 |
% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220215006101/en/
INVESTOR CONTACT:
Investors@endava.com
Source:
FAQ
What were Endava's Q2 FY2022 earnings results?
What is Endava's revenue guidance for Q3 FY2022?
How did Endava perform in terms of adjusted EPS in Q2 FY2022?
What factors drove Endava's revenue growth in Q2 FY2022?